[Streptococcus pneumoniae: serotypes, invasive and antibiotic resistant strains. Current situation in France].

Abstract

Bacterio-clinical surveillance networks provide regular epidemiological data aimed at better use of antibiotics and the promotion of vaccination campaigns. In the future, the vaccination of children under 2 years of age with new conjugated polysaccharide vaccines should be an essential step in the global strategy against pneumococcal infections. The vaccinal formula of such a pediatric vaccine would contain 10 valences, defined according to the serotype results we have obtained: 1, 3, 4, 6, 7, 9, 14, 18, 19, 13. This vaccine would cover 86.1% of the invasive strains and 90.7% of the strains isolated from children with acute otitismedia.